MedPath

Investigating changes in hippocampal volume and regional cerebral perfusion and therapeutic and system related outcomes following the treatment of Post Traumatic Stress Disorder with Eye Movement Desensitization Reprocessing and exposure therapy: a pilot study.

Not Applicable
Recruiting
Registration Number
ACTRN12611000843954
Lead Sponsor
Murdoch University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Currently diagnosable with PTSD (via assessment interview and CAPS form 2); willing to engage in psychological treatment; consenting to neuroimaging and audio-taped interviews.

Exclusion Criteria

Current drug or alcohol dependence; diabetes; currently pregnant or breast feeding; past history of psychotic illness; previously diagnosed organic brain disorder; evidence of diagnosable cluster B Personality Disorder (via SCID II); currently on Psychotropic based medications; unable to cope with confined spaces or needles; any metal implants.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath